FORENAP, your Key-partner
FORENAP Pharma manages the development of your compounds from preclinical to phase II studies. FORENAP Pharma offers preclinical and clinical development plans, a partner’s network for preclinical studies, and its own 72-bed centre for phase I studies. For phase II studies, FORENAP Pharma can act as an investigator centre or a coordinator centre thanks to its investigator’s network in France and in several European countries.
FORENAP Pharma can take care of the overall development of your compound :
- Investigator’s brochure writing
- Protocol design
- Legal authorities submission
- Pharmaceutical development
- Realization of clinical part
- Subjects recruitment
- Monitoring
- Data management
- Biostatistics
- Report writing of trials
For bioclinical studies, the technical platform is one of FORENAP Pharma’s major asset: it offers among other tools wake EEG, polysomnography, magnetic resonance imaging (MRI), magnetoencephalography (MEG), driving simulator, neurocognitive tests…
20 years of experience always do the difference
